TH1902 in Patients With Advanced Solid Tumors

NCT04706962 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
TNBC - Triple-Negative Breast Cancer
Hormone Receptor-positive Breast Cancer
Epithelial Ovarian Cancer
Endometrial Cancer
Cutaneous Melanoma
Thyroid Cancer
Small-cell Lung Cancer
Prostate Cancer
SORT1+ Cancers

Interventions

DRUG: TH1902

Sponsor

Theratechnologies

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]